Plain-English translation of NCT07245134 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing virtual reality exposure therapy—a treatment that uses special VR glasses to help people with obsessive-compulsive disorder (OCD) practice facing situations that trigger their symptoms in a safe, controlled way. Therapists guide participants through realistic home scenarios tailored to their specific OCD patterns, such as contamination fears or compulsive checking. The goal is to see whether this VR-based approach works better than standard therapy alone or than playing cognitive training games in VR.
Current treatments for OCD, like exposure therapy, are effective but can be difficult or uncomfortable to practice in real life. This trial explores whether virtual reality offers a new way to deliver this proven therapy—one that's safer to practice, easier to customize to each person's needs, and potentially more effective.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be assigned to one of three groups. One group will complete six weeks of standard therapy plus five weekly sessions wearing VR glasses in a virtual house where you'll practice facing situations that trigger your OCD symptoms—therapists will adjust the difficulty as you progress. The other groups will either receive standard therapy plus VR cognitive training games, or standard therapy alone. Each VR session lasts 30–40 minutes, and you'll attend one per week for six weeks.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Czechia